Ivan Hirsch

3.3k total citations
107 papers, 2.4k citations indexed

About

Ivan Hirsch is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Ivan Hirsch has authored 107 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Virology, 41 papers in Epidemiology and 40 papers in Immunology. Recurrent topics in Ivan Hirsch's work include HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (23 papers) and Immune Cell Function and Interaction (23 papers). Ivan Hirsch is often cited by papers focused on HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (23 papers) and Immune Cell Function and Interaction (23 papers). Ivan Hirsch collaborates with scholars based in France, Czechia and United States. Ivan Hirsch's co-authors include Daniel Olive, Jean‐Claude Chermann, Françoise Gondois‐Rey, Beda Břicháček, Jiřı́ Hejnar, Kateřina Trejbalová, V. Vonka, Jana Blažková, Giselle Sánchez and Angélique Biancotto and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Ivan Hirsch

105 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Hirsch France 28 1.0k 898 777 769 536 107 2.4k
Beda Břicháček United States 25 1.5k 1.4× 864 1.0× 882 1.1× 653 0.8× 675 1.3× 68 2.6k
John Hackett United States 29 686 0.7× 1.4k 1.6× 783 1.0× 407 0.5× 524 1.0× 75 2.9k
Jean‐Marie Andrieu France 28 1.2k 1.1× 953 1.1× 586 0.8× 511 0.7× 449 0.8× 89 2.8k
Bindong Liu United States 22 2.0k 1.9× 865 1.0× 1.2k 1.6× 883 1.1× 965 1.8× 35 2.8k
Jesper Melchjorsen Denmark 26 468 0.5× 1.4k 1.6× 521 0.7× 818 1.1× 564 1.1× 35 2.3k
Sentob Saragosti France 28 1.8k 1.8× 489 0.5× 1.4k 1.8× 621 0.8× 1.1k 2.1× 68 3.3k
Gerald Nakamura United States 30 1.8k 1.7× 1.2k 1.4× 817 1.1× 880 1.1× 1.3k 2.4× 45 3.6k
Guido Vanham Belgium 34 1.6k 1.6× 1.7k 1.9× 1.3k 1.7× 779 1.0× 946 1.8× 104 3.6k
M Montroni Italy 23 1.9k 1.8× 1.1k 1.3× 1.1k 1.4× 625 0.8× 277 0.5× 47 2.8k
Simon Monard United States 18 2.0k 2.0× 2.0k 2.2× 760 1.0× 854 1.1× 544 1.0× 29 3.4k

Countries citing papers authored by Ivan Hirsch

Since Specialization
Citations

This map shows the geographic impact of Ivan Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Hirsch more than expected).

Fields of papers citing papers by Ivan Hirsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Hirsch. The network helps show where Ivan Hirsch may publish in the future.

Co-authorship network of co-authors of Ivan Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Hirsch. A scholar is included among the top collaborators of Ivan Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Hirsch. Ivan Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plecitá‐Hlavatá, Lydie, et al.. (2025). STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction. Cell Death Discovery. 11(1). 494–494.
2.
Janovec, V., Jan Hodek, Jiří Froněk, et al.. (2020). Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes. Scientific Reports. 10(1). 12767–12767. 18 indexed citations
3.
Lubyová, Barbora, et al.. (2017). PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS ONE. 12(10). e0186982–e0186982. 42 indexed citations
4.
Letard, Sébastien, Jonathan Florentin, Jan Weber, et al.. (2016). Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells. PLoS ONE. 11(6). e0156063–e0156063. 26 indexed citations
5.
Gondois‐Rey, Françoise, et al.. (2012). Multiparametric cytometry for exploration of complex cellular dynamics. Cytometry Part A. 81A(4). 332–342. 9 indexed citations
6.
Florentin, Jonathan, Christine Thumann, Françoise Gondois‐Rey, et al.. (2012). HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood. 120(23). 4544–4551. 47 indexed citations
7.
Bozzano, Federica, A. Picciotto, Paola Costa, et al.. (2011). Activating NK cell receptor expression/function (NKp30, NKp46, DNAM‐1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. European Journal of Immunology. 41(10). 2905–2914. 61 indexed citations
8.
Břicháček, Beda, Christophe Vanpouille, Angélique Biancotto, et al.. (2010). Contrasting Roles for TLR Ligands in HIV-1 Pathogenesis. PLoS ONE. 5(9). e12831–e12831. 31 indexed citations
9.
Hirsch, Ivan, Christophe Caux, Uzma Hasan, Nathalie Bendriss‐Vermare, & Daniel Olive. (2010). Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends in Immunology. 31(10). 391–397. 79 indexed citations
10.
Castellano, Rémy, Bérengère Vire, Marjorie Pion, et al.. (2006). Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling. Journal of Biological Chemistry. 281(21). 14719–14728. 15 indexed citations
11.
Gondois‐Rey, Françoise, Jean‐Charles Grivel, Angélique Biancotto, et al.. (2002). Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. AIDS. 16(9). 1245–1249. 21 indexed citations
12.
Gondois‐Rey, Françoise, Angélique Biancotto, Marjorie Pion, et al.. (2001). Production of HIV-1 by resting memory T lymphocytes. AIDS. 15(15). 1931–1940. 13 indexed citations
13.
Devergié, A, André Baruchel, Patricia Ribaud, et al.. (1995). Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.. PubMed. 15(6). 943–7. 23 indexed citations
14.
Hammar, Lena Marmstål, et al.. (1994). Lectin Effects on HIV‐1 Infectivity. Annals of the New York Academy of Sciences. 724(1). 166–169. 6 indexed citations
15.
Gluckman, Éliane, R Traineau, A Devergié, H Espérou-Bourdeau, & Ivan Hirsch. (1992). Prevention and treatment of CMV infection after allogeneic bone marrow transplant. Annals of Hematology. 64(S1). A158–A161. 8 indexed citations
16.
Kutinová, L, Šárka Němečková, Eva Hamšíková, et al.. (1990). A recombinant vaccinia virus expressing hepatitis B virus middle surface protein Restricted expression of HBV antigens in human diploid cells. Archives of Virology. 112(3-4). 181–193. 11 indexed citations
17.
Boldogh, István, et al.. (1985). Viral DNA sequences in human cytomegalovirus transformed hamster cell line at low passage levels.. PubMed. 32(2). 147–54. 1 indexed citations
18.
Hirsch, Ivan, et al.. (1979). Blocking of Acid-fixed Nuclear Binding of Epstein-Barr Virus Nuclear Antigen (EBNA) by Different DNA Species. Journal of General Virology. 44(3). 849–852. 2 indexed citations
19.
Hirsch, Ivan, et al.. (1977). Studies on the intracellular replicating DNA of herpes simplex virus type 1. Virology. 81(1). 48–61. 35 indexed citations
20.
Hirsch, Ivan, et al.. (1976). Replicating DNA of Herpes Simplex Virus Type 1. Intervirology. 7(3). 155–175. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beda Břicháček Breakdown of academic impact, for papers by John Hackett Breakdown of academic impact, for papers by Jean‐Marie Andrieu Breakdown of academic impact, for papers by Bindong Liu Breakdown of academic impact, for papers by Jesper Melchjorsen Breakdown of academic impact, for papers by Sentob Saragosti Breakdown of academic impact, for papers by Gerald Nakamura Breakdown of academic impact, for papers by Guido Vanham Breakdown of academic impact, for papers by M Montroni Breakdown of academic impact, for papers by Simon Monard
Rankless by CCL
2026